BIGLARI HOLDINGS INC-B (BH) Stock Fundamental Analysis

NYSE:BH • US08986R3093

387.78 USD
-3.38 (-0.86%)
At close: Feb 27, 2026
387.78 USD
0 (0%)
After Hours: 2/27/2026, 8:04:00 PM
Fundamental Rating

3

BH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 125 industry peers in the Hotels, Restaurants & Leisure industry. No worries on liquidiy or solvency for BH as it has an excellent financial health rating, but there are worries on the profitability. BH is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year BH was profitable.
  • In the past year BH had a positive cash flow from operations.
  • In multiple years BH reported negative net income over the last 5 years.
  • Each year in the past 5 years BH had a positive operating cash flow.
BH Yearly Net Income VS EBIT VS OCF VS FCFBH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

  • BH has a worse Return On Assets (0.19%) than 65.08% of its industry peers.
  • Looking at the Return On Equity, with a value of 0.36%, BH is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • With a Return On Invested Capital value of 2.19%, BH is not doing good in the industry: 69.05% of the companies in the same industry are doing better.
  • Measured over the past 3 years, the Average Return On Invested Capital for BH is significantly below the industry average of 10.88%.
Industry RankSector Rank
ROA 0.19%
ROE 0.36%
ROIC 2.19%
ROA(3y)0.71%
ROA(5y)0.47%
ROE(3y)0.87%
ROE(5y)0.38%
ROIC(3y)4.28%
ROIC(5y)4.07%
BH Yearly ROA, ROE, ROICBH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

  • BH's Profit Margin of 0.54% is on the low side compared to the rest of the industry. BH is outperformed by 60.32% of its industry peers.
  • The Operating Margin of BH (6.19%) is comparable to the rest of the industry.
  • BH's Operating Margin has improved in the last couple of years.
  • BH has a worse Gross Margin (38.28%) than 67.46% of its industry peers.
  • BH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.19%
PM (TTM) 0.54%
GM 38.28%
OM growth 3Y-13.98%
OM growth 5Y50.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.62%
GM growth 5Y13.62%
BH Yearly Profit, Operating, Gross MarginsBH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BH is destroying value.
  • The number of shares outstanding for BH remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for BH has been reduced compared to 5 years ago.
  • Compared to 1 year ago, BH has a worse debt to assets ratio.
BH Yearly Shares OutstandingBH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
BH Yearly Total Debt VS Total AssetsBH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 2.61 indicates that BH is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • BH's Altman-Z score of 2.61 is fine compared to the rest of the industry. BH outperforms 69.84% of its industry peers.
  • BH has a debt to FCF ratio of 3.77. This is a good value and a sign of high solvency as BH would need 3.77 years to pay back of all of its debts.
  • BH has a better Debt to FCF ratio (3.77) than 79.37% of its industry peers.
  • A Debt/Equity ratio of 0.48 indicates that BH is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.48, BH is in the better half of the industry, outperforming 65.08% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 3.77
Altman-Z 2.61
ROIC/WACC0.27
WACC8.21%
BH Yearly LT Debt VS Equity VS FCFBH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

  • BH has a Current Ratio of 2.83. This indicates that BH is financially healthy and has no problem in meeting its short term obligations.
  • BH has a Current ratio of 2.83. This is amongst the best in the industry. BH outperforms 92.86% of its industry peers.
  • A Quick Ratio of 2.80 indicates that BH has no problem at all paying its short term obligations.
  • The Quick ratio of BH (2.80) is better than 93.65% of its industry peers.
Industry RankSector Rank
Current Ratio 2.83
Quick Ratio 2.8
BH Yearly Current Assets VS Current LiabilitesBH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

0

3. Growth

3.1 Past

  • BH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -94.31%.
  • Looking at the last year, BH shows a small growth in Revenue. The Revenue has grown by 6.87% in the last year.
  • Measured over the past years, BH shows a very negative growth in Revenue. The Revenue has been decreasing by -11.55% on average per year.
EPS 1Y (TTM)-94.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-117.77%
Revenue 1Y (TTM)6.87%
Revenue growth 3Y-0.36%
Revenue growth 5Y-11.55%
Sales Q2Q%10.32%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BH Yearly Revenue VS EstimatesBH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
BH Yearly EPS VS EstimatesBH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 -2 -4 -6 -8

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 76.04, the valuation of BH can be described as expensive.
  • Based on the Price/Earnings ratio, BH is valued a bit more expensive than the industry average as 63.49% of the companies are valued more cheaply.
  • Compared to an average S&P500 Price/Earnings ratio of 27.07, BH is valued quite expensively.
Industry RankSector Rank
PE 76.04
Fwd PE N/A
BH Price Earnings VS Forward Price EarningsBH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • BH's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, BH is valued cheaper than 89.68% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.9
EV/EBITDA 11.3
BH Per share dataBH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for BH!.
Industry RankSector Rank
Dividend Yield 0%

BIGLARI HOLDINGS INC-B

NYSE:BH (2/27/2026, 8:04:00 PM)

After market: 387.78 0 (0%)

387.78

-3.38 (-0.86%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-27
Earnings (Next)05-07
Inst Owners93.18%
Inst Owner Change1.28%
Ins Owners0.4%
Ins Owner Change0%
Market Cap884.14M
Revenue(TTM)386.51M
Net Income(TTM)2.09M
Analysts43.33
Price TargetN/A
Short Float %40.42%
Short Ratio1.22
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 76.04
Fwd PE N/A
P/S 2.29
P/FCF 10.9
P/OCF 8.25
P/B 1.52
P/tB 1.75
EV/EBITDA 11.3
EPS(TTM)5.1
EY1.32%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)35.59
FCFY9.18%
OCF(TTM)47.01
OCFY12.12%
SpS169.52
BVpS254.51
TBVpS221.07
PEG (NY)N/A
PEG (5Y)N/A
Graham Number170.89
Profitability
Industry RankSector Rank
ROA 0.19%
ROE 0.36%
ROCE 2.55%
ROIC 2.19%
ROICexc 3.61%
ROICexgc 4.17%
OM 6.19%
PM (TTM) 0.54%
GM 38.28%
FCFM 20.99%
ROA(3y)0.71%
ROA(5y)0.47%
ROE(3y)0.87%
ROE(5y)0.38%
ROIC(3y)4.28%
ROIC(5y)4.07%
ROICexc(3y)5.11%
ROICexc(5y)4.86%
ROICexgc(3y)5.84%
ROICexgc(5y)5.56%
ROCE(3y)5.05%
ROCE(5y)4.78%
ROICexgc growth 3Y-14.08%
ROICexgc growth 5Y44.59%
ROICexc growth 3Y-14.03%
ROICexc growth 5Y43.14%
OM growth 3Y-13.98%
OM growth 5Y50.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.62%
GM growth 5Y13.62%
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 3.77
Debt/EBITDA 4.35
Cap/Depr 64.86%
Cap/Sales 6.74%
Interest Coverage 250
Cash Conversion 167.28%
Profit Quality 3878.39%
Current Ratio 2.83
Quick Ratio 2.8
Altman-Z 2.61
F-Score4
WACC8.21%
ROIC/WACC0.27
Cap/Depr(3y)72.81%
Cap/Depr(5y)99.4%
Cap/Sales(3y)7.64%
Cap/Sales(5y)9.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-94.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-117.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.87%
Revenue growth 3Y-0.36%
Revenue growth 5Y-11.55%
Sales Q2Q%10.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.66%
EBIT growth 3Y-14.29%
EBIT growth 5Y33.25%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y51.75%
FCF growth 3Y-51.22%
FCF growth 5Y-24.16%
OCF growth 1Y39.79%
OCF growth 3Y-39.9%
OCF growth 5Y-11.92%

BIGLARI HOLDINGS INC-B / BH FAQ

What is the fundamental rating for BH stock?

ChartMill assigns a fundamental rating of 3 / 10 to BH.


What is the valuation status for BH stock?

ChartMill assigns a valuation rating of 2 / 10 to BIGLARI HOLDINGS INC-B (BH). This can be considered as Overvalued.


How profitable is BIGLARI HOLDINGS INC-B (BH) stock?

BIGLARI HOLDINGS INC-B (BH) has a profitability rating of 3 / 10.


What is the financial health of BIGLARI HOLDINGS INC-B (BH) stock?

The financial health rating of BIGLARI HOLDINGS INC-B (BH) is 7 / 10.